Evofem Biosciences, Inc. (EVFM)
OTCMKTS · Delayed Price · Currency is USD
0.0088
0.00 (0.00%)
Apr 1, 2025, 3:12 PM EST

Evofem Biosciences Statistics

Total Valuation

EVFM has a market cap or net worth of 1.07 million. The enterprise value is 51.69 million.

Market Cap 1.07M
Enterprise Value 51.69M

Important Dates

The last earnings date was Monday, March 3, 2025.

Earnings Date Mar 3, 2025
Ex-Dividend Date n/a

Share Statistics

EVFM has 113.36 million shares outstanding. The number of shares has decreased by -92.36% in one year.

Current Share Class n/a
Shares Outstanding 113.36M
Shares Change (YoY) -92.36%
Shares Change (QoQ) +9.67%
Owned by Insiders (%) 0.00%
Owned by Institutions (%) 0.09%
Float 113.35M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.04
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -5.77
EV / Sales 2.67
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -13.26

Financial Position

The company has a current ratio of 0.17

Current Ratio 0.17
Quick Ratio 0.12
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF -11.79
Interest Coverage -2.98

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -27.94%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 13.55%
Revenue Per Employee 605,094
Profits Per Employee -280,156
Employee Count 32
Asset Turnover 1.13
Inventory Turnover 2.34

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -62.74% in the last 52 weeks. The beta is -0.74, so EVFM's price volatility has been lower than the market average.

Beta (5Y) -0.74
52-Week Price Change -62.74%
50-Day Moving Average 0.01
200-Day Moving Average 0.01
Relative Strength Index (RSI) 51.18
Average Volume (20 Days) 588,811

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.11

Income Statement

In the last 12 months, EVFM had revenue of 19.36 million and -8.97 million in losses. Loss per share was -0.12.

Revenue 19.36M
Gross Profit 15.53M
Operating Income -7.68M
Pretax Income -8.86M
Net Income -8.97M
EBITDA -7.03M
EBIT -7.68M
Loss Per Share -0.12
Full Income Statement

Balance Sheet

The company has 127,000 in cash and 45.97 million in debt, giving a net cash position of -45.84 million or -0.40 per share.

Cash & Cash Equivalents 127,000
Total Debt 45.97M
Net Cash -45.84M
Net Cash Per Share -0.40
Equity (Book Value) -66.48M
Book Value Per Share -0.63
Working Capital -66.84M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -3.89 million and capital expenditures -14,000, giving a free cash flow of -3.90 million.

Operating Cash Flow -3.89M
Capital Expenditures -14,000
Free Cash Flow -3.90M
FCF Per Share -0.03
Full Cash Flow Statement

Margins

Gross margin is 80.20%, with operating and profit margins of -39.64% and -45.76%.

Gross Margin 80.20%
Operating Margin -39.64%
Pretax Margin -45.76%
Profit Margin -45.76%
EBITDA Margin -36.29%
EBIT Margin -39.64%
FCF Margin n/a

Dividends & Yields

EVFM does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 92.36%
Shareholder Yield 92.36%
Earnings Yield -841.35%
FCF Yield -365.91%

Stock Splits

The last stock split was on May 18, 2023. It was a reverse split with a ratio of 0.008.

Last Split Date May 18, 2023
Split Type Reverse
Split Ratio 0.008

Scores

EVFM has an Altman Z-Score of -56.44. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -56.44
Piotroski F-Score n/a